跳至主要内容
临床试验/NCT07388771
NCT07388771招募中不适用

A Study on Multimodal Data Prediction of Outcome to Neoadjuvant Therapy in NSCLC

Qian Chu1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
pathologic response

研究概览

简要总结

This observational study aims to construct and validate the performance of a multimodal predictive model in forecasting the outcomes of neoadjuvant therapy in patients with NSCLC.

The core research question is: Can a multi-model approach predict outcomes of neoadjuvant therapy for non-small cell lung cancer and provide clinical recommendations?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pathologically diagnosed non-small cell lung cancer
  • The treatment plan is:receiving neoadjuvant chemo-immunotherapy during the study period, followed by surgical resection

排除标准

  • recurrent or metastatic lung cancer;
  • patients with other primary tumors

研究组 & 干预措施

NSCLC with neoadjuvant therapy but without surgery

NSCLC with neoadjuvant therapy and surgery

结局指标

主要结局

pathologic response

时间窗: Perioperative

次要结局

  • EFS(One year after the treatment ended)

研究者

发起方
Qian Chu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Qian Chu

Director of the Thoracic Oncology Department

Tongji Hospital

研究点 (1)

Loading locations...

相似试验